Dr Fabien Plisson is a chemist and a data scientist. For the last 15 years, Fabien has contributed to various research programs in drug discovery between academic institutions and industry partners worldwide. His work combines laboratory and computational strategies, including advanced statistics and machine learning algorithms, to unmet medical needs: antimicrobial resistance, cancer treatments, type 2 diabetes, neurodegenerative disorders and malaria. His group combines the fields of protein engineering, drug discovery and artificial intelligence to discover and design novel therapeutics.